The FFR guidewire market will continue to grow due to positive clinical results from increased ease-of-use thanks to FFR console integration into cath labs.
Vancouver, BC (PRWEB) June 12, 2015
According to a recently published report by iData Research (http://www.idataresearch.com), new technologies like fractional flow reserve (FFR) guide-wires within the diagnostic coronary catheters and guide-wires market is one the fastest growing segments within the interventional cardiology market. Despite the adoption of alternative screening methods and limited unit sales due to a recent decrease in angioplasties, the rapidly growing adoption of FFR guide-wires has alleviated sales pressure significantly.
“The FFR guide-wire market will continue to grow due to positive clinical results from increased ease-of-use thanks to FFR console integration into cath labs,” explains Dr. Kamran Zamanian, CEO of iData. “Additionally, FFR guided percutaneous coronary intervention procedures cost less than standard procedures without prolonging procedure times.”
As procedure numbers increase over time, so will the sales of diagnostic catheters. However, unit growth will be lower in comparison to the rise in rate of procedures. The reason for this difference is that the progression of transthoracic technology has been applied to diagnostic procedures, allowing the left ventricle to be accessed without a catheter. Therefore, despite an increase in procedures being performed, fewer catheters are being used per procedure.
The high rates of obesity, diabetes and the increasing age of the U.S population has made the population more aware of the dangers of cardiovascular disease. This has increased the overall number of screening procedures in the country.
Volcano Therapeutics is the leading competitor in the FFR guide-wire market where they have over half the market share. Because of the high value of the FFR guide-wire market, Volcano’s strong market share in this rapidly growing segment translated into nearly 30% of the overall diagnostic coronary catheters and guide-wires market. Volcano has gained market share in the FFR guide-wire market because of the integration of their FFR devices into their newest intravascular ultrasound consoles. As demand for combination devices increases, Volcano will be well placed to capitalize on the opportunity and increase their share in the market.
Other notable competitors in the diagnostic coronary catheter and guide-wire market include St. Jude Medical, Cordis, Boston Scientific, Medtronic, Cook Medical, Merit Medical Systems, C.R. Bard, Abbott Laboratories, AngioDynamics, St. Jude Medical, Terumo, and Teleflex Medical among others.
For Further Information
More on the diagnostic coronary catheter and guide-wire market in the U.S. can be found in the report published by iData entitled U.S. Market for Interventional Cardiology Devices. This report also covers the U.S. market segments for bare-metal and drug-eluting stents, PTCA and cutting balloons, balloon-inflation devices, interventional coronary catheters, interventional coronary guide-wires, coronary embolic protection devices, coronary atherectomy devices, coronary thrombectomy devices, coronary chronic total occlusion crossers, introducer sheaths, coronary vascular closure devices, diagnostic coronary catheter and guidewires, intravascular ultrasound catheters, and optical coherence tomography catheters.
The iData series on the market for interventional cardiology devices covers the U.S., Japan, Brazil, and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
To find out more about U.S interventional cardiology market data or procedure data, register online or email us at firstname.lastname@example.org for a U.S. Market for Interventional Cardiology Devices report brochure and synopsis.
About Procedure Tracker
Additional procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology, and more.